[en] Main problems which should be solved: - To create the new highly productive recombinant GENI stain-producer - To select the medium and cultivation's conditions for stain-producer. - To elaborate the separation and purification GENI technology. In order to create the new GENI stain-producer we need significantly change the separation and purification's technology which was elaborated according to traditional method before. The separation and purification GENI's technology demand the industrial methods utilization, such as: ultrafiltration, high-and-low pressures chromatography. Besides, the utilization of recombinant micro-organisms, required for to obtain the medicinal preparations, places a constraint on the quality controls ready made product which should be in conformity with following conditions: high trustworthiness, reproducibility and sensitivity. In this connection, we need to perform a series of the work concerning with analytic controls methods of production and substance preparations technology. To create the separation and purification GENt technology on the highly productive recombinant GENI Stain-producers base. To put in an application in order to patient this new stain. The results of these works will be base for to prepare the normative-technical documents concerning with GENI substances production. Also, we will make the initial data and plan required for to project the GENI substances production. This work will be performed without foreign partner's participation

No abstract available

[en] While MEMS-based transdermal drug delivery device development efforts have typically focused on tightly-integrated solutions, we propose an alternate conception based upon a novel, modular drug reservoir approach. By decoupling the drug storage functionality from the rest of the delivery system, this approach seeks to minimize cold chain storage volume, enhance compatibility with conventional pharmaceutical practices, and allow independent optimization of reservoir device design, materials, and fabrication. Herein, we report the design, fabrication, and preliminary characterization of modular reservoirs that demonstrate the virtue of this approach within the application context of transdermal insulin administration for diabetes management. (technical note)

[en] It was reported that the a-helix of protein molecules could be destroyed when they were exposed to the electromagnetic field (EMF) and finally the signal transduction could be affected. To study this effect, one signal molecule, insulin, was exposed to electromagnetic fields at different combinations of the field strength, repetition rate and exposure time. For the first time, structural biology approach was used to detect the EMF effect. The results of a series of measurements on the interaction of electromagnetic fields with insulin in vitro are described. Under our experimental conditions, no effects of electromagnetic field exposure were observed on the molecular conformation. (authors)

[en] Short communication

No abstract available

[en] There is a growing epidemic of insulin resistance syndrome (IRS) in Indians. We postulate that increased susceptibility of the urban Indians to insulin resistance is a result of a tendency to increased fat deposition from the time of intrauterine life (thrifty phenotype), exaggerated in the urban environment by a positive energy balance. The pro-inflammatory cytokines secreted by the inflammatory cells as well by the adipose tissue could aggravate insulin resistance and endothelial damage and therefore, increase the susceptibility to type 2 diabetes and coronary heart disease (CHD) independent of the previously proposed glucose fatty acid cycle mechanism. In a preliminary study, we propose to make detailed measurements of the proposed mechanisms in a selected population from 3 geographical locations in and near the city of Pune, India and also validate simple 'epidemiologic' measurements of body composition with 'reference' measurements. One hundred men (30 to 50y) each from the three geographical locations (rural, urban slum-dwellers and urban middle class in Pune) will be studied for: (i) Body composition: Anthropometric and bioimpedance measurement of total body fat (to be calibrated against deuterated water in 30 subjects from each location), and muscle mass by anthropometry and urinary creatinine excretion; (ii) Body fat distribution by subscapular- triceps ratio, waist-hip ratio; (iii) Metabolic: Glucose tolerance and insulin resistance variables (insulin, lipids, NEFA) and leptin; (iv) Endothelial markers: e-Selectin and von Willebrand Factor (vWF); (v) Inflammatory markers and pro-inflammatory cytokines: C-reactive protein (CRP), Interleukin-6 (IL-6) and tumour necrosis factor (TNF- α); (vi) Energy Balance: Assessment of nutritional intake (calories, carbohydrates, proteins and fats, n3 and n6 fatty acids) and physical activity by a questionnaire. Insulin resistance variables, endothelial markers, cytokines and obesity parameters will be compared in the 3 groups. Energy intake and physical activity will be related to obesity parameters and n3 and n6 fatty acid intake will be related to inflammatory markers. Multivariate analysis will be used to explore the independent contributions of levels of circulating cytokines and of obesity to insulin resistance syndrome variables and endothelial markers, controlling for place of residence. (author)

[en] Thyroid hormones (T3 et T4) were coupled to bovine serum albumin (BSA) with glutaraldehyde in a two stage reaction. The different molecules applied at each stage of the coupling procedure were studied by UV-visible spectrophotometry. The coupling ratios of T3/BSA and T4/BSA were respectively 23 and 8. The electrophoretic motility of the conjugates in one band indicated that the products developed were homogeneous. Polyclonal antibodies were produced by rabbit immunizations with intradermal injections of the thyroid hormone immunogens emulsified in complete Freund's adjuvant. The antibodies developed have high titre and specificity. Thus, they could easily be used in the development of immunoassay procedures for the determination of the total thyroid hormones or of the free fractions. (author). 12 refs, 2 figs

[en] The results of a comparative evaluation of seven immunometric TSH kits are presented. These include data on reproducibility, sensitivity, precision, bias, parallelism, cross reactivity and a clinical assessment of the kits. It was concluded that five of the kits have the potential to meet the high sensitivity requirements for clinical diagnostic application and particular aspects of performance of each of these kits are presented which may help in the selection of a method appropriate to local circumstances. (UK)

No abstract available